Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Suppression”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Testing effectiveness (Phase 2)Ended earlyNCT03059355
What this trial is testing

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Who this might be right for
Endothelial DysfunctionMetabolic SyndromeChronic Inflammation
Joshua M Hare 14
Testing effectiveness (Phase 2)UnknownNCT00243165
What this trial is testing

Lifemel Honey to Reduce Leucopenia During Chemotherapy

Who this might be right for
Breast Cancer
Rambam Health Care Campus 60
Not applicableUnknownNCT04905329
What this trial is testing

Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Who this might be right for
Solid TumorHigh-Risk CancerBreast Cancer+3 more
Moscow Clinical Scientific Center 285
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06714266
What this trial is testing

Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Shandong Cancer Hospital and Institute 30
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Post-approval studies (Phase 4)UnknownNCT03793205
What this trial is testing

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Who this might be right for
Gynecologic CancerMyelosuppression AdultFebrile Neutropenia+1 more
Lei Li 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06370416
What this trial is testing

The Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Who this might be right for
Non-small Cell Lung Cancer
Henan Cancer Hospital 41
Testing effectiveness (Phase 2)UnknownNCT01762514
What this trial is testing

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

Who this might be right for
Nasopharyngeal NeoplasmsSalivary Gland DiseasesBone Marrow Diseases+1 more
Sun Yat-sen University 360
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Testing effectiveness (Phase 2)Study completedNCT02692742
What this trial is testing

Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-Induced NeutropeniaMyelosuppressionBreast Cancer
Myelo Therapeutics GmbH 137
Testing effectiveness (Phase 2)Study completedNCT00001749
What this trial is testing

Medical Treatment for Diamond Blackfan Anemia

Who this might be right for
Fanconi's AnemiaHematologic Disease
National Heart, Lung, and Blood Institute (NHLBI) 25
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Early research (Phase 1)Study completedNCT01633229
What this trial is testing

Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications

Who this might be right for
Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 10
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Not applicableLooking for participantsNCT07819656
What this trial is testing

Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Myelosuppression
Nanfang Hospital, Southern Medical University 1,782
Testing effectiveness (Phase 2)Looking for participantsNCT07205536
What this trial is testing

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Who this might be right for
MyelosuppressionThoracic NeoplasmsChemoradiotherapy
Affiliated Hospital of Nantong University 30
Next Page